ENV-294 for Moderate-to-Severe Asthma: A 12-Week Study in Adults

Recruiting

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(14 sites)

United States

AllerVie Clinical Research, Birmingham, Alabama

California Allergy and Asthma Medical, Los Angeles, California

Allergy and Asthma Associates of Santa Clara Valley Research Center, San Jose, California

Asthma and Allergy Associates, Colorado Springs, Colorado

New Life Medical Research Center, Hialeah, Florida